Sensing of Immature Particles Produced by Dengue Virus Infected Cells Induces an Antiviral Response by Plasmacytoid Dendritic Cells

PLoS Pathogens

Volumn 10, Issue 10, 2014, Pages

  Décembre, Elodie ^a   Assil, Sonia ^a   Hillaire, Marine L B ^a   Dejnirattisai, Wanwisa ^b   Mongkolsapaya, Juthathip ^b,c   Screaton, Gavin R ^b   Davidson, Andrew D ^d   Dreux, Marlène ^a  

^a UNIVERSITÉ DE LYON   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 6; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; CELL MATURATION; CONFOCAL MICROSCOPY; DENGUE VIRUS; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MALE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VESICULAR STOMATITIS VIRUS; VIRUS INFECTIVITY; WEST NILE FLAVIVIRUS; WESTERN BLOTTING; ACTIN FILAMENT; CELL LINE; DENDRITIC CELL; EVOLUTION; IMMUNOLOGY; MEMBRANE FUSION; METABOLISM; PHYSIOLOGY; VIROLOGY;

DENGUE VIRUS;

ACTIN CYTOSKELETON; BIOLOGICAL EVOLUTION; CELL LINE; DENDRITIC CELLS; DENGUE VIRUS; HUMANS; IMMUNITY, INNATE; MEMBRANE FUSION; VIRAL ENVELOPE PROTEINS;

EID: 84908346054     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004434     Document Type: Article

References (73)

1. Kawai T, Akira S, (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637–650.
2. Loo YM, Gale M, Jr (2011) Immune signaling by RIG-I-like receptors. Immunity 34: 680–692.
3. Dreux M, Garaigorta U, Boyd B, Decembre E, Chung J, et al. (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12: 558–570.
4. Wieland SF, Takahashi K, Boyd B, Whitten-Bauer C, Ngo N, et al. (2014) Human plasmacytoid dendritic cells sense lymphocytic choriomeningitis virus-infected cells in vitro. J Virol 88: 752–757.
5. Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, et al. (2010) Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A 107: 7431–7436.
6. Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, et al. (2011) Innate sensing of HIV-infected cells. PLoS Pathog 7: e1001284.
7. Python S, Gerber M, Suter R, Ruggli N, Summerfield A, (2013) Efficient sensing of infected cells in absence of virus particles by plasmacytoid dendritic cells is blocked by the viral ribonuclease E(rns.). PLoS Pathog 9: e1003412.
8. Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135: 37–48.
9. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V, (2011) Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 29: 163–183.
10. Versteeg GA, Garcia-Sastre A, (2010) Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 13: 508–516.
11. Morrison J, Aguirre S, Fernandez-Sesma A, (2012) Innate immunity evasion by Dengue virus. Viruses 4: 397–413.
12. Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, et al. (2012) DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 8: e1002934.
13. Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, et al. (2012) Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog 8: e1002780.
14. Anglero-Rodriguez YI, Pantoja P, Sariol CA, (2014) Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IkappaB kinase epsilon interaction. Clin Vaccine Immunol 21: 29–38.
15. Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, et al. (2010) Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 84: 9760–9774.
16. Simmons CP, Popper S, Dolocek C, Chau TN, Griffiths M, et al. (2007) Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 195: 1097–1107.
17. de Kruif MD, Setiati TE, Mairuhu AT, Koraka P, Aberson HA, et al. (2008) Differential gene expression changes in children with severe dengue virus infections. PLoS Negl Trop Dis 2: e215.
18. Martina BE, Koraka P, Osterhaus AD, (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564–581.
19. Sariol CA, Martinez MI, Rivera F, Rodriguez IV, Pantoja P, et al. (2011) Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS ONE 6: e19323.
20. Pasquato A, Ramos da Palma J, Galan C, Seidah NG, Kunz S, (2013) Viral envelope glycoprotein processing by proprotein convertases. Antiviral Res 99: 49–60.
21. Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, van der Ende-Metselaar H, Lei HY, et al. (2010) Immature dengue virus: a veiled pathogen? PLoS Pathog 6: e1000718.
22. Rodenhuis-Zybert IA, Wilschut J, Smit JM, (2011) Partial maturation: an immune-evasion strategy of dengue virus? Trends Microbiol 19: 248–254.
23. Keelapang P, Sriburi R, Supasa S, Panyadee N, Songjaeng A, et al. (2004) Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses. J Virol 78: 2367–2381.
24. Wang S, He R, Anderson R, (1999) PrM- and cell-binding domains of the dengue virus E protein. J Virol 73: 2547–2551.
25. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, et al. (2007) Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81: 12019–12028.
26. Junjhon J, Lausumpao M, Supasa S, Noisakran S, Songjaeng A, et al. (2008) Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction. J Virol 82: 10776–10791.
27. Pierson TC, Diamond MS, (2012) Degrees of maturity: the complex structure and biology of flaviviruses. Curr Opin Virol 2: 168–175.
28. Zellweger RM, Prestwood TR, Shresta S, (2010) Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7: 128–139.
29. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C, (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529–1531.
30. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A, (2007) Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315: 1398–1401.
31. Kroschewski H, Lim SP, Butcher RE, Yap TL, Lescar J, et al. (2008) Mutagenesis of the dengue virus type 2 NS5 methyltransferase domain. J Biol Chem 283: 19410–19421.
32. Kroschewski H, Sagripanti JL, Davidson AD, (2009) Identification of amino acids in the dengue virus type 2 envelope glycoprotein critical to virus infectivity. J Gen Virol 90: 2457–2461.
33. Zheng A, Umashankar M, Kielian M, (2010) In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions. PLoS Pathog 6: e1001157.
34. Thitithanyanont A, Engering A, Ekchariyawat P, Wiboon-ut S, Limsalakpetch A, et al. (2007) High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol 179: 5220–5227.
35. Westcott MM, Ahmed M, Smedberg JR, Rajani KR, Hiltbold EM, et al. (2013) Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein. J Virol 87: 11730–11740.
36. Mukhopadhyay S, Kuhn RJ, Rossmann MG, (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3: 13–22.
37. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, et al. (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839–850.
38. Wang LH, Rothberg KG, Anderson RG, (1993) Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123: 1107–1117.
39. Achuthan A, Masendycz P, Lopez JA, Nguyen T, James DE, et al. (2008) Regulation of the endosomal SNARE protein syntaxin 7 by colony-stimulating factor 1 in macrophages. Mol Cell Biol 28: 6149–6159.
40. Haspot F, Lavault A, Sinzger C, Laib Sampaio K, Stierhof YD, et al. (2012) Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PLoS ONE 7: e34795.
41. Russo C, Cornella-Taracido I, Galli-Stampino L, Jain R, Harrington E, et al. (2011) Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells. Blood 117: 5683–5691.
42. Bershadsky A, Chausovsky A, Becker E, Lyubimova A, Geiger B, (1996) Involvement of microtubules in the control of adhesion-dependent signal transduction. Curr Biol 6: 1279–1289.
43. Eligini S, Songia P, Cavalca V, Crisci M, Tremoli E, et al. (2012) Cytoskeletal architecture regulates cyclooxygenase-2 in human endothelial cells: autocrine modulation by prostacyclin. J Cell Physiol 227: 3847–3856.
44. Young KG, Thurston SF, Copeland S, Smallwood C, Copeland JW, (2008) INF1 is a novel microtubule-associated formin. Mol Biol Cell 19: 5168–5180.
45. Mateo R, Nagamine CM, Spagnolo J, Mendez E, Rahe M, et al. (2013) Inhibition of cellular autophagy deranges dengue virion maturation. J Virol 87: 1312–1321.
46. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504–507.
47. Whitehorn J, Simmons CP, (2011) The pathogenesis of dengue. Vaccine 29: 7221–7228.
48. Gandini M, Gras C, Azeredo EL, Pinto LM, Smith N, et al. (2013) Dengue virus activates membrane TRAIL relocalization and IFN-alpha production by human plasmacytoid dendritic cells in vitro and in vivo. PLoS Negl Trop Dis 7: e2257.
49. Pichyangkul S, Endy TP, Kalayanarooj S, Nisalak A, Yongvanitchit K, et al. (2003) A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J Immunol 171: 5571–5578.
50. Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A, (2010) Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 84: 4845–4850.
51. Sun P, Fernandez S, Marovich MA, Palmer DR, Celluzzi CM, et al. (2009) Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology 383: 207–215.
52. Yu IM, Zhang W, Holdaway HA, Li L, Kostyuchenko VA, et al. (2008) Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319: 1834–1837.
53. Moesker B, Rodenhuis-Zybert IA, Meijerhof T, Wilschut J, Smit JM, (2010) Characterization of the functional requirements of West Nile virus membrane fusion. J Gen Virol 91: 389–393.
54. Yu IM, Holdaway HA, Chipman PR, Kuhn RJ, Rossmann MG, et al. (2009) Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol 83: 12101–12107.
55. Blasius AL, Beutler B, (2010) Intracellular toll-like receptors. Immunity 32: 305–315.
56. Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, et al. (2009) Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. Embo J 28: 3269–3276.
57. Plevka P, Battisti AJ, Junjhon J, Winkler DC, Holdaway HA, et al. (2011) Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres. EMBO Rep 12: 602–606.
58. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, et al. (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328: 745–748.
59. Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, et al. (2010) The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8: 271–283.
60. Luo YY, Feng JJ, Zhou JM, Yu ZZ, Fang DY, et al. (2013) Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody. BMC Microbiol 13: 194.
61. Galloway SE, Reed ML, Russell CJ, Steinhauer DA, (2013) Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9: e1003151.
62. Matczuk AK, Kunec D, Veit M, (2013) Co-translational processing of glycoprotein 3 from equine arteritis virus: N-glycosylation adjacent to the signal peptide prevents cleavage. J Biol Chem 288: 35396–35405.
63. Fujinami RS, Oldstone MB, (1981) Failure to cleave measles virus fusion protein in lymphoid cells. J Exp Med 154: 1489–1499.
64. Steinhauer DA, (1999) Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258: 1–20.
65. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102: 9294–9299.
66. Pryor MJ, Carr JM, Hocking H, Davidson AD, Li P, et al. (2001) Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am J Trop Med Hyg 65: 427–434.
67. Pierson TC, Diamond MS, Ahmed AA, Valentine LE, Davis CW, et al. (2005) An infectious West Nile virus that expresses a GFP reporter gene. Virology 334: 28–40.
68. Ostertag D, Hoblitzell-Ostertag TM, Perrault J, (2007) Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response. J Virol 81: 503–513.
69. Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, et al. (2010) Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells. J Immunol 185: 4812–4823.
70. Sumpter R, Loo YM, Foy E, Li K, Yoneyama M, et al. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689–2699.
71. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, et al. (2012) The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12: 544–557.
72. Dreux M, Dao Thi VL, Fresquet J, Guerin M, Julia Z, et al. (2009) Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog 5: e1000310.
73. Pryor MJ, Azzola L, Wright PJ, Davidson AD, (2004) Histidine 39 in the dengue virus type 2 M protein has an important role in virus assembly. J Gen Virol 85: 3627–3636.